Table of Contents Table of Contents
Previous Page  237 / 258 Next Page
Information
Show Menu
Previous Page 237 / 258 Next Page
Page Background

F

eng

et al

.:

J

ournal of

AOAC I

nternational

V

ol

.

100, N

o

.

2, 2017 

519

Figure 13. E-gram of infant formula 4 with CGMP-reduced sweet whey ingredient (70% whey claim).

Figure 14. E-gram of infant formula 5 with sweet whey ingredient (40% whey claim).

Table 8. Protein profile of bovine milk and calculated whey

protein as the mass percentage of casein (4, 5)

Protein

MW, kDa

Whole milk content

g/L (5)

%

a

S1-casein

23.69

10.0

30.3

a

S2-casein

25.31

2.6

7.9

b

-Casein

23.97

9.3

28.2

k

-Casein

21.30

3.3

10.0

g

-Casein

20.59

0.8

2.4

a

-Lac

14.19

1.2

3.6

BSA

67.41

0.4

1.2

Immunoglobulin

160.00

0.8

2.4

Peptone 5

12.43

0.5

1.5

Peptone 3

17.89

0.3

0.9

LF

78.06

0.1

0.3

Milk fat globule

membrane

0.4

1.2

b

-Lg

18.27

3.3

10.0

CGMP

9.15

 Sum

33.0

100.0

 Casein

26.0

78.8

 Whey

7.0

21.2

 Whey as percentage

of casein

26.9

26.9

ratio from the literature with the area percentage ratio obtained

with the SDS-CGE method. Based on the literature mass

percentage ratio (26.9%) and the experimental area percentage

ratio (20.8%), a CF of 1.29 should be applied to the integrated

signal of whey proteins.

To evaluate the impact of the infant formula manufacturing

process on the area CF of whey proteins to caseins, a whey

protein-dominant infant formula was manufactured. Two

samples were taken; one before processing and one after. The

test results are listed in Table 10 and indicate that processing

further increased this ratio 1.11-fold. Therefore, a final CF of

1.4 for whey protein-to-casein area for infant formulas was

chosen (Table 9).

Forty-three infant formulas manufactured by both Chinese

and international manufacturers with different whey ingredients,

including regular sweet whey, α-Lac-enriched whey, LF-added

whey, and casein glycomacropeptide (CGMP)-reduced whey,

were analyzed and compared with manufacturers’ claims

(Table 11). The results show that among the 41 samples with

manufacturers’ claims, measured whey content was in close

agreement with declared value: within 5% of the declared value

for 31 (76%) samples and within 10% for 37 (90%) samples.

Two infant formulas did not contain added whey protein; hence,

a factor of 1.29, not 1.4, should be used. Taking this into account,

39 (95%) samples were within 10% of the declared value.

237